Lesniowski-Crohn disease and colon cancer
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 4
Abstract
Non-specific, granulomatous inflammation of the colon called Lesniowski-Crohn disease is one of the chronic illnesses predisposing to the large intestine cancer. The prevalence of this disease increases in proportion with civilization progress of the society. The etiology of the disease has not been recognized in detail, the prevailing opinion is that it is a result of the series of factors: heterogeneous and genetic. The research published with participation of patients is not abounding, however, it suggests that the risk of falling ill with cancer of the large intestine, its outlook and a 5-year survival do not significantly differ from the results achieved in patients with ulcerative colitis. An unambiguous treatment and supervision model within the scope of prevention of the cancer of the large intestine in patients with Lesniowski Crohn disease have not been worked out yet. However, it seems that for an early detection of displasia and cancer it is significant to carry out colonoscopy, chromoendoscopy with collection of numerous biopsies. An increased prevalence of cancer of the large intestine and Lesniowski-Crohn disease may contribute to the necessity of working out an algorithm of procedures for these patients. However, most often, detection of cancer of the large intestine in patients with Lesniowski-Crohn disease is unintentional and thus is a challenge for the modern diagnostics of the inflammatory diseases of the large intestine.
Authors and Affiliations
Michał Jankowski, Wojciech Zegarski
Keywords
Related Articles
- EP ID EP123557
- DOI -
- Views 65
- Downloads 0
Treatment of basal cell epithelioma which has been growing for many years - a case report
Basal cell carcinoma (Ca basocellulare, basal cell epithelioma, basalioma, rodent ulcer) is the most common skin cancer. Skin cancers develop in sun-exposed areas and are common in men after the age of 40. Basal cell ca...
Effectiveness and toxicity of Interleukin 2, Interferon α, and 5-Fluorouracil in patients with Metastatic Renal Cell Cancer
Purpose: The purpose of this study was to evaluate the potential efficacy and toxicity for the treatment of metastatic renal cell cancer. Material and methods: During the first 4 weeks of treatment, patients rec...
Squamous cell carcinoma antigen (SCC) in diagnostics and monitoring treatment of patients with cervical cancer
Squamous cell carcinoma antigen (SCC) is the first marker of squamous cell carcinoma and a member of the serin proteinase inhibitor family. Increased concentration of SCC occurs in squamous cancers of the region of the h...
Nowe możliwości leczenia kwasem zoledronowym przerzutów do kości w przebiegu raka gruczołu krokowego, na tle zdobyczy badań molekularnych
Rak gruczołu krokowego jest nadal poważnym wyzwaniem. Na świecie stale obserwuje się ogromną liczbę zachorowań. Rak gruczołu krokowego jest głównie rozpoznawany w krajach wysoko uprzemysłowionych. Sposób odżywiania i try...
Immunoterapia raka jelita grubego
Immunoterapia raka jelita grubego mimo wielu napotkanych niepowodzeń powoli toruje sobie drogę do szerokiego zastosowania. Na przestrzeni lat immunoterapia raka jelita grubego przeszła od nieswoistych czynników immunomod...